The effect of red palm olein and refined palm olein on lipids and haemostatic factors in hyperfibrinogenaemic subjects

Thrombosis Research

Volumn 113, Issue 1, 2004, Pages 13-25

  Scholtz, Susanna C ^a   Pieters, Marlien ^a   Oosthuizen, Welma ^a   Jerling, Johann C ^a   Bosman, Magdalena J C ^a   Vorster, Hester H ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Cardiovascular disease; CVD; Fibrin network structure; Fibrinogen; Haemostatic factors; LDLC; Monounsaturated fatty acids; MUFA; Palm oil; Palm olein; PO; POL; Red palm olein; Refined palm olein; RPO; Saturated fatty acids; Serum lipids; SFA

Indexed keywords

ANTIGEN; CHOLESTEROL; FIBRIN; HEMOSTATIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALM OIL; SUNFLOWER OIL; TISSUE PLASMINOGEN ACTIVATOR; TRIOLEIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DYSFIBRINOGENEMIA; FEMALE; HUMAN; HYPERFIBRINOGENEMIA; MAJOR CLINICAL STUDY; MALE; PHYSIOLOGY; PLANT; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SUNFLOWER;

ADULT; BODY MASS INDEX; DIET; DIETARY FATS; DOUBLE-BLIND METHOD; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; LIPIDS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PLANT OILS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 1842788175     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.02.004     Document Type: Article

References (51)

1. Ong A.S., Goh S.H. Palm oil: a healthful and cost-effective dietary component. Food Nutr. Bull. 23:2002;11-22.
2. O'Holohan D.R. Malaysian palm oil: the story of a major edible vegetable oil and its role in human nutrition. 1997;Malaysian Palm Oil Promotion Council, Kuala Lumpur.
3. Ng T.K.W. A critical review of the cholesterolemic effects of palm oil. Food Nutr. Bull. 15:1994;112-117.
4. Sundram K. Modulation of human lipids and lipoproteins by dietary palm oil and palm oil: a review. Asia Pac. J. Clin. Nutr. 6:1997;12-16.
5. Manorama R., Jyothermia R.S., Aparna K. Effect of supplementation of red palm olein on serum lipid and antioxidant levels of healthy human subjects and iron absorption in anemic adolescent girls. Proceedings of the PORIM international palm oil congress-nutrition conference. 1999;134-146 Palm Oil Research Institute of Malaysia, Kuala Lumpur (Malaysia).
6. Qureshi A.A., Bradlow B.A., Brace L., Manganello J., Peterson D.M., Pearce B.C.et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids. 30:1995;1171-1177.
7. Qureshi A.A., Qureshi N., Wright J.J., Shen Z., Kramer G., Gapor A.et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am. J. Clin. Nutr. 53:1991;1021S-1026S.
8. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb. Haemost. 89:2003;601-609.
9. Vorster H.H., Cummings J.H., Jerling J.C. Diet and haemostatic processes. Nutr. Res. Rev. 10:1997;115-135.
10. Marckmann P. Diet, blood coagulation and fibrinolysis. Dan. Med. Bull. 42:1995;410-425.
11. De Bosch N.B., Bosch V., Apitz R. Dietary fatty acids in athero-thrombogenesis: influence of palm oil ingestion. Haemostasis. 26(Suppl. 4):1996;46-54.
12. Hunter K.A., Crosbie L.C., Weir A., Miller G.J., Dutta-Roy A.K. The effects of structurally defined triglycerides of differing fatty acid composition on postprandial haemostasis in young, healthy men. Atherosclerosis. 142:1999;151-158.
13. Pereira T.A., Shahi G.S., Das N.P. Effects of dietary palm oil on serum lipid peroxidation, antithrombin III, plasma cyclic AMP, and platelet aggregation. Biochem. Med. Metabol. Biol. 45:1991;326-332.
14. Rand M.L., Hennissen A.A., Hornstra G. Effects of dietary palm oil on arterial thrombosis, platelet responses and platelet membrane fluidity in rats. Lipids. 23:1988;1019-1023.
15. Salomaa V.V., Salminen I., Rasi V., Vahtera E., Aro A., Myllyla G. Association of the fatty acid composition of serum phospholipids with hemostatic factors. Arterioscler. Thromb. Vasc. Biol. 17:1997;809-813.
16. Temme E.H., Mensink R.P., Hornstra G. Individual saturated fatty acids and effects on whole blood aggregation in vitro. Eur. J. Clin. Nutr. 52:1998;697-702.
17. Fatah K., Hamsten A., Blomback B., Blomback M. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis. Thromb. Haemost. 68:1992;130-135.
18. Fatah K., Silveira A., Tornvall P., Karpe F., Blomback M., Hamsten A. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb. Haemost. 76:1996;535-540.
19. Bosman M.J.C., Vorster H.H., Drewnowski A., Steyn H.S. Consumer acceptance of high-fibre muffins containing Simplesse® J. Diet. Home Econ. 25:1997;90-99.
20. Manorama R., Rukmini C. Crude palm oil as a source of beta-carotene. Nutr. Res. 12:1992;S223-32.
21. Manorama R., Rukmini C. Effect of processing on beta-carotene retention in crude palm oil and its products. Food Chem. 42:1991;253-264.
22. Medical Research Council of South Africa Food finder 2. 2000;MRC Press, Tygerberg.
23. Langenhoven M.L., Kruger M., Gouws E., Faber M. MRC food composition tables. 3rd ed. 1991;National Research Institute for Nutritional Disease of the South African Medical Research Council, Parow.
24. Smuts C.M., Kruger M., van Jaarsveld P.J., Fincham J.E., Schall R., van der Merwe K.J.et al. The influence of fish oil supplementation on plasma lipoproteins and arterial lipids in vervet monkeys with established atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids. 47:1992;129-138.
25. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
26. Blombäck B., Carlsson K., Fatah K., Hessel B., Procyk R. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb. Res. 75:1994;521-538.
27. Dhall T.Z., Bryce W.A., Dhall D.P. Effects of dextran on the molecular structure and tensile behaviour of human fibrin. Thromb. Haemost. 35:1976;737-745.
28. Nair C.H., Azhar A., Dhall D.P. Studies on fibrin network structure in human plasma: Part One. Methods for clinical application. Thromb. Res. 64:1991;455-476.
29. Hunter J.E. Studies on effects of dietary fatty acids as related to their position on triglycerides. Lipids. 36:2001;655-668.
30. Wood R., Kubena K., Tseng S., Martin G., Crook R. Effect of palm oil, margarine, butter and sunflower oil on the serum lipids and lipoproteins of normocholesterolemic middle-aged men. J. Nutr. Biochem. 4:1993;286-297.
31. Hellsten G., Boman K., Bjerle P., Blom P., Nilsson T.K. Increased plasminogen activator inhibitor and tissue plasminogen activator levels in subjects with electrocardiographic abnormality indicative of ischaemic heart disease: a cross-sectional study in Norsjo, Sweden. Eur. Heart J. 13:1992;57-60.
32. Fukao H., Ueshima S., Okada K., Yamamoto K., Matsuo T., Matsuo O. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. Thromb. Res. 68:1992;57-65.
33. Smith F.B., Lee A.J., Rumley A., Fowkes F.G., Lowe G.D. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis. 115:1995;35-43.
34. Yamada S., Yamada R., Ishii A., Ashikawa K., Kawamitsu H., Fujita K. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction. J. Cardiol. 27:1996;171-178.
35. Yamauchi K., Suzuki T., Furumichi T., Saito H. Plasma t-PA/PAI-1 complex and blood coagulability in patients with coronary artery disease. Jpn. Heart J. 33:1992;351-358.
36. Chandler W.L., Jascur M.L., Henderson P.J. Measurement of different forms of tissue plasminogen activator in plasma. Clin. Chem. 46:2000;38-46.
37. Eliasson M., Asplund K., Evrin P.-E., Huhtasaari F., Johansson I. Plasma fibrinogen, fibrinolysis and (pro)vitamins: is there a connection? Fibrinolysis. 9:1995;87-92.
38. Van Poppel G., Hospers J., Nieuwenhuizen W., Laterveer R. No influence of beta-carotene on haemostatic balance in healthy male smokers. Blood Coagul. Fibrinolysis. 6:1995;55-59.
39. Tholstrup T., Marckmann P., Jespersen J., Sandstrom B. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am. J. Clin. Nutr. 59:1994;371-377.
40. Tholstrup T., Marckmann P., Jespersen J., Vessby B., Jart A., Sandstrom B. Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am. J. Clin. Nutr. 60:1994;919-925.
41. Mensink R.P., van Houwelingen A.C., Kromhout D., Hornstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am. J. Clin. Nutr. 69:1999;213-219.
42. Theriault A., Chao J.T., Wang Q., Gapor A., Adeli K. Tocotrienol: a review of its therapeutic potential. Clin. Biochem. 32:1999;309-319.
43. Steiner M., Anastasia J. Vitamin E and platelet aggregation. Am. J. Clin. Nutr. 57:1975;732-737.
44. Wahlqvist M.L., Krivokuca-Bogetic Z., Lo C.S., Hage B., Smith R., Lukito W. Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolemic individuals without change in coronary risk factors. Nutr. Res. 12:1992;S181-S201.
45. Veldman F.J., Nair C.H., Vorster H.H., Vermaak W.J., Jerling J.C., Oosthuizen W.et al. Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects. Thromb. Res. 86:1997;183-196.
46. Moss S.J., Malan M.M., Dreyer L.I., Vorster H.H. Fibrin network structure. Changes in characteristics in response to physical activity in combination with a pre-exercise meal. Ann. N. Y. Acad. Sci. 936:2001;634-638.
47. Blomback B., Blomback M., Carlsson K., Fatah K., Hamsten A., Hessel B. Fibrin gel structure in health and disease. Ernst E., Koenig W., Lowe G.D., Meade T.W. Fibrinogen: a "new" cardiovascular risk factor. 1992;11-18 Blackwell, Vienna.
48. Blomback B., Okada M. Fibrin gel structure and clotting time. Thromb. Res. 25:1982;51-70.
49. Shah G.A., Nair C.H., Dhall D.P. Physiological studies on fibrin network structure. Thromb. Res. 40:1985;181-188.
50. Nair C.H., Shats E.A. Compaction as a method to characterise fibrin network structure: kinetic studies and relationship to crosslinking. Thromb. Res. 88:1997;381-387.
51. Ryan E.A., Mockros L.F., Weisel J.W., Lorand L. Structural origins of fibrin clot rheology. Biophys. J. 77:1999;2813-2826.